Schiereck P, De Beer E, Van Heijst B, Janssen P, Van Andel A, Jennekens F, Sontrop A, Bavinck A
Department of Medical Physiology and Sports Medicine, University Utrecht, Netherlands.
Eur J Pharmacol. 1993 Nov 16;249(3):317-24. doi: 10.1016/0014-2999(93)90528-p.
Striated muscle fibres, both skeletal and cardiac of different species including human, skinned by freeze-drying, were activated in solutions strongly buffered for Ca2+. The single fibres were immersed in solutions with different [Ca2+]. Sarcomere length was set and controlled by laser diffraction. Fibre type was determined by Sr2+ activation. The relation between the negative logarithm of the Ca2+ concentration and the normalized tension, the Ca2+ sensitivity curve, was investigated. The effect on the contractile machinery of three different Ca2+ channel antagonists (verapamil, diltiazem and nifedipine) in a therapeutic concentration (10(-6) M) was investigated. The possible effects on the Ca2+ sensitivity curve were quantified by: (1) the change in maximal tension developed at pCa2+ = 4.4; (2) the change in pCa2+ value at which 50% of the tension induced at pCa2+ = 4.4; (3) the steepness of the Ca2+ sensitivity curve in this point. The three drugs tested, at a therapeutic concentration of 1 microM, all enhanced maximal induced tension by respectively 25, 20 and 7%. The sarcomere length dependency of the effect proved to be dependent upon the drug, but also slightly on fibre type (skeletal or cardiac), or on species. It is concluded that the drug influences the cooperativity of the two different types of binding sites on troponin-C (low- and high-affinity sites). Tension enhancement was due to increased stiffness of the actin-myosin interaction site.
包括人类在内的不同物种的横纹肌纤维,无论是骨骼肌还是心肌,通过冻干去皮后,在对Ca2+进行强缓冲的溶液中被激活。将单根纤维浸入不同[Ca2+]的溶液中。肌节长度通过激光衍射设定和控制。纤维类型通过Sr2+激活来确定。研究了Ca2+浓度的负对数与归一化张力之间的关系,即Ca2+敏感性曲线。研究了三种不同的Ca2+通道拮抗剂(维拉帕米、地尔硫䓬和硝苯地平)在治疗浓度(10(-6) M)下对收缩机制的影响。通过以下方式对Ca2+敏感性曲线的可能影响进行量化:(1) 在pCa2+ = 4.4时产生的最大张力的变化;(2) 在pCa2+ = 4.4时诱导的张力的50%时的pCa2+值的变化;(3) 该点处Ca2+敏感性曲线的陡度。所测试的三种药物在1 microM的治疗浓度下,均分别使最大诱导张力提高了25%、20%和7%。结果证明,该效应的肌节长度依赖性取决于药物,但也略微取决于纤维类型(骨骼肌或心肌)或物种。得出的结论是,该药物影响肌钙蛋白-C上两种不同类型结合位点(低亲和力和高亲和力位点)的协同作用。张力增强是由于肌动蛋白-肌球蛋白相互作用位点的刚度增加。